ATE274058T1 - Biotinbindende rezeptormoleküle - Google Patents

Biotinbindende rezeptormoleküle

Info

Publication number
ATE274058T1
ATE274058T1 AT99906341T AT99906341T ATE274058T1 AT E274058 T1 ATE274058 T1 AT E274058T1 AT 99906341 T AT99906341 T AT 99906341T AT 99906341 T AT99906341 T AT 99906341T AT E274058 T1 ATE274058 T1 AT E274058T1
Authority
AT
Austria
Prior art keywords
biotin
receptor molecules
binding receptor
domain
binding
Prior art date
Application number
AT99906341T
Other languages
English (en)
Inventor
Seppo A I Virtan Yla-Herttuala
Markku Kulomaa
Pauliina A I Virta Lehtolainen
Varpu Marjomaki
Kari Airenne
Original Assignee
Ark Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9803757.5A external-priority patent/GB9803757D0/en
Priority claimed from GBGB9813653.4A external-priority patent/GB9813653D0/en
Application filed by Ark Therapeutics Ltd filed Critical Ark Therapeutics Ltd
Application granted granted Critical
Publication of ATE274058T1 publication Critical patent/ATE274058T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99906341T 1998-02-23 1999-02-23 Biotinbindende rezeptormoleküle ATE274058T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9803757.5A GB9803757D0 (en) 1998-02-23 1998-02-23 Fusion proteins
GBGB9813653.4A GB9813653D0 (en) 1998-06-24 1998-06-24 Fusion proteins
PCT/GB1999/000546 WO1999042577A2 (en) 1998-02-23 1999-02-23 Biotin-binding receptor molecules

Publications (1)

Publication Number Publication Date
ATE274058T1 true ATE274058T1 (de) 2004-09-15

Family

ID=26313170

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99906341T ATE274058T1 (de) 1998-02-23 1999-02-23 Biotinbindende rezeptormoleküle

Country Status (16)

Country Link
US (1) US7208291B2 (de)
EP (1) EP1056850B1 (de)
JP (1) JP2002504328A (de)
KR (1) KR100722578B1 (de)
CN (1) CN1195852C (de)
AT (1) ATE274058T1 (de)
AU (1) AU750444B2 (de)
CA (1) CA2319039A1 (de)
DE (1) DE69919515T2 (de)
DK (1) DK1056850T3 (de)
ES (1) ES2226340T3 (de)
HU (1) HUP0101614A3 (de)
NO (1) NO328139B1 (de)
PL (1) PL195990B1 (de)
PT (1) PT1056850E (de)
WO (1) WO1999042577A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040209294A1 (en) * 2002-09-02 2004-10-21 National Food Research Institute Method to produce a receptor chip using biotinylated protein
US9623117B2 (en) * 2011-04-04 2017-04-18 Wisconsin Alumni Research Foundation Method for selective targeting and entry of bacterial toxins to cells
KR20230007559A (ko) * 2013-12-20 2023-01-12 프레드 허친슨 캔서 센터 태그된 키메라 이펙터 분자 및 그의 리셉터
WO2016176652A2 (en) 2015-04-29 2016-11-03 Fred Hutchinson Cancer Research Center Modified stem cells and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839293A (en) * 1986-02-24 1989-06-13 The Trustees Of Columbia University In The City Of New York DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
CA1340977C (en) * 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
US5457035A (en) * 1993-07-23 1995-10-10 Immunex Corporation Cytokine which is a ligand for OX40
US5846537A (en) 1995-06-07 1998-12-08 University Of Rochester Modified avidin and streptavidin and methods of use thereof
US6497881B1 (en) * 1995-11-30 2002-12-24 New York University High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein

Also Published As

Publication number Publication date
PL343079A1 (en) 2001-07-30
KR100722578B1 (ko) 2007-05-28
ES2226340T3 (es) 2005-03-16
CN1195852C (zh) 2005-04-06
HUP0101614A3 (en) 2006-04-28
CA2319039A1 (en) 1999-08-26
JP2002504328A (ja) 2002-02-12
NO20004195D0 (no) 2000-08-22
WO1999042577A2 (en) 1999-08-26
PT1056850E (pt) 2004-12-31
AU750444B2 (en) 2002-07-18
EP1056850B1 (de) 2004-08-18
NO20004195L (no) 2000-08-22
WO1999042577A3 (en) 1999-10-21
KR20010085196A (ko) 2001-09-07
DE69919515T2 (de) 2005-04-07
US7208291B2 (en) 2007-04-24
NO328139B1 (no) 2009-12-14
EP1056850A2 (de) 2000-12-06
US20040185059A1 (en) 2004-09-23
DK1056850T3 (da) 2004-11-29
AU2631299A (en) 1999-09-06
CN1291230A (zh) 2001-04-11
DE69919515D1 (de) 2004-09-23
PL195990B1 (pl) 2007-11-30
HUP0101614A2 (hu) 2001-09-28

Similar Documents

Publication Publication Date Title
DK0888385T3 (da) GDNF receptor og anvendelser deraf
AU2001294060A1 (en) Chimeric cytoplasmic signalling molecules derived from cd137
CY1107133T1 (el) Κυκλικοι ανταγωνιστες των υποδοχεων c5a και συζευγμενοι με πρωτεϊνη g υποδοχεις
EP1849866A3 (de) Menschliche, an ein G-Protein gekoppelte Rezeptoren ohne bekannte Liganden
DK1115381T3 (da) Indgivelsessystem til proteinformige lægemidler, hvor der anvendes membranmimetika
BR0010215A (pt) Derivados de indolina como antagonistas de progesterona
BRPI0409701A (pt) ligantes de receptores de canabinóides e seus usos
DE69838061D1 (de) Typ ii tgf-beta receptor/immunoglobulin konstante domäne fusionsproteine
EA199900912A1 (ru) Фармацевтические средства
ES2147167T1 (es) Procedimiento de identificacion de moduladores de receptores de membrana de superficie celular util para el tratamiento de enfermedades.
AU2001245209A1 (en) Screening methods for bone morphogenetic mimetics
DE69919515D1 (de) Biotinbindende rezeptormoleküle
DE59907939D1 (de) Vorrichtung für den Beschnitt von Broschüren
NO20061015L (no) Fremgangsmate for rensing av et ikke-immunglobulinprotein som omfatter et immunglobulinlignende (Ig-lignende) domene
ATE312915T1 (de) Neurturin-rezeptor
EP0995430A3 (de) Verwendung von Wirkstoffen, gewählt aus der Gruppe der 1,2-Diacylglycerole, zur Stärkung der Barrierefunktion der Haut
WO2000052039A3 (en) Lectomedin materials and methods
NO20024779L (no) G-protein-koblet reseptor
ATA218998A (de) Übertragungssystem zur übertragung von sprachinformationen
AU5168800A (en) Structural models for cytoplasmic domains of transmembrane receptors
DE69535039D1 (de) Cytoplasmische tyrosin kinase
DK1207876T3 (da) Anvendelse af en modulator, som virker på en vækstfaktorpræcursor for at inhibere forarbejdningen af vækstfaktorpræcursor
FR2730489B1 (fr) Derives de 1-(2-(vinyl-substitues))-5h-2,3-benzodiazepine
TR200102093T2 (tr) Organ koruyucu çözeltiler
DE69840418D1 (de) Träger für halbdurchlässige membran

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1056850

Country of ref document: EP

REN Ceased due to non-payment of the annual fee